No abstract available
Keywords:
JAK inhibitor; atopic dermatitis; biologic failure; dupilumab; upadacitinib.
MeSH terms
-
Adult
-
Antibodies, Monoclonal, Humanized / adverse effects
-
Dermatitis, Atopic* / drug therapy
-
Humans
-
Retrospective Studies
-
Severity of Illness Index
-
Treatment Outcome
Substances
-
dupilumab
-
upadacitinib
-
Antibodies, Monoclonal, Humanized